Browsing Tag
Valerio Therapeutics
2 posts
Valerio Therapeutics to buy Etherna for €30m; raises €40.25m
The €40.25 million PIPE is larger than Etherna’s €30 million enterprise value, giving Valerio capital not only for the acquisition but also for pipeline development and in-house GMP RNA manufacturing.
Valerio Therapeutics and Abivax target next-generation therapies for inflammatory disease
Valerio may gain cash and platform validation from Abivax, but definitive terms and preclinical delivery will decide whether the alliance creates value.